Article Details

First Patient Dosed in Phase 2 IGNAZ Study of Felzartamab in Patients with Immunoglobulin A ...

Retrieved on: 2021-10-21 09:23:03

Tags for this article:

Click the tags to see associated articles and topics

First Patient Dosed in Phase 2 IGNAZ Study of Felzartamab in Patients with Immunoglobulin A .... View article details on hiswai:

Excerpt

Felzartamab (MOR202) is an investigational therapeutic human monoclonal antibody derived from MorphoSys' HuCAL(R) antibody library and directed ...

Article found on: pipelinereview.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up